Companies: 10,795·Total market cap: $144.5T
Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG.CNCNQHealthcare● Active
$96.12
$-6.55(-6.38%)
Market Cap$746036822
P/E Ratio
52W High$170
52W Low$33.01
Overview

Bright Minds Biosciences Inc.(DRUG.CN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

drug.cn · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 4 位华尔街分析师

SellBuy

Buy

4 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
合计: 4 · 买入占比: 100.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $96.12

Bright Minds Biosciences Inc.(DRUG.CN)的分析师共识为 Buy,基于过去 3 个月内 4 位华尔街分析师的评级。DRUG.CN 的 12 个月平均目标价为 $0.00,相对当前价 $96.12 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$92.084.21%

1-day model range: $91.39–$92.76. Peak: $92.76 (-4.21%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$83-13.3%
2028$77-19.7%
2029$74-22.9%
2030$72-24.6%
2031-25.5%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)43.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · DRUG.CN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$105.12SELL
MA 10$112.50SELL
MA 20$111.98SELL
MA 50$113.43SELL
MA 100$111.71SELL
MA 200$99.15SELL
Current $DRUG.CN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$104.45SELL
EMA 10$108.75SELL
EMA 20$111.57SELL
EMA 50$112.44SELL
EMA 100$109.23SELL
EMA 200$98.95SELL
Current $DRUG.CN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-06-01
Maintains
BuyBuy
Piper Sandler2026-05-20
Maintains
OverweightOverweight
BTIG2026-03-30
Maintains
BuyBuy
HC Wainwright & Co.2026-03-04
Maintains
BuyBuy
BTIG2026-02-17
Maintains
BuyBuy
BTIG2026-01-07
Maintains
BuyBuy
BTIG2026-01-06
Maintains
BuyBuy
Chardan Capital2026-01-02
Maintains
BuyBuy
HC Wainwright & Co.2025-12-30
Maintains
BuyBuy
HC Wainwright & Co.2025-09-15
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Bright Minds Biosciences Inc. (DRUG.CN) stock. Of the recent 13 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover DRUG.CN.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

DRUG.CN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 100.0% YoY

Revenue Next Year

$40M

EPS This Year

$-6.50

EPS Next Year

$-12.81

↑ 97.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast DRUG.CN EPS of $-6.50 for the current fiscal year, based on estimates from 6 analysts. The DRUG.CN revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

DRUG.CN 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。DRUG.CN 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

DRUG.CN 的短期预测(明日)为 $92.08(-4.21%)。 DRUG.CN 对 2027 年的股价预测均值为 $83。 DRUG.CN 对 2030 年的预测区间为 $67–$78。

Bright Minds Biosciences Inc. 在 CNQ 上市,代码 DRUG.CN。DRUG.CN 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

DRUG.CN 预测 · 8 个问题

根据 4 位华尔街分析师,DRUG.CN 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $96.12,隐含约 +0.0% 的上行空间。

DRUG.CN 目标价DRUG.CN 分析师目标价DRUG.CN 12个月目标价目标价 DRUG.CN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.